{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T16:19:11Z","timestamp":1770740351998,"version":"3.49.0"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"9-10","license":[{"start":{"date-parts":[[2022,9,26]],"date-time":"2022-09-26T00:00:00Z","timestamp":1664150400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,9,26]],"date-time":"2022-09-26T00:00:00Z","timestamp":1664150400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Wien Med Wochenschr"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1007\/s10354-022-00965-8","type":"journal-article","created":{"date-parts":[[2022,9,26]],"date-time":"2022-09-26T13:04:00Z","timestamp":1664197440000},"page":"201-205","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Gastrointestinale Stromatumoren (GIST)","Gastrointestinal stromal tumors (GIST)"],"prefix":"10.1007","volume":"173","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9738-233X","authenticated-orcid":false,"given":"David","family":"Jaros","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Boris","family":"Bozic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Sebesta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,9,26]]},"reference":[{"issue":"9896","key":"965_CR1","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1016\/S0140-6736(13)60106-3","volume":"382","author":"H Joensuu","year":"2013","unstructured":"Joensuu\u00a0H, Hohenberger\u00a0P, Corless\u00a0CL. Gastrointestinal stromal tumour. Lancet Lond Engl. 2013;382(9896):973\u201383.","journal-title":"Lancet Lond Engl"},{"key":"965_CR2","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s13569-017-0072-8","volume":"7","author":"I Judson","year":"2017","unstructured":"Judson\u00a0I, Bulusu\u00a0R, Seddon\u00a0B, Dangoor\u00a0A, Wong\u00a0N, Mudan\u00a0S. UK clinical practice guidelines for the management of gastrointestinal stromal tumours (GIST). Clin Sarcoma Res. 2017;7:6.","journal-title":"Clin Sarcoma Res"},{"issue":"2","key":"965_CR3","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1200\/JCO.2017.74.9705","volume":"36","author":"M von Mehren","year":"2018","unstructured":"von Mehren\u00a0M, Joensuu\u00a0H. Gastrointestinal stromal tumors. J\u00a0Clin Oncol. 2018;36(2):136\u201343.","journal-title":"J Clin Oncol"},{"key":"965_CR4","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.canep.2015.10.031","volume":"40","author":"K S\u00f8reide","year":"2016","unstructured":"S\u00f8reide\u00a0K, Sandvik\u00a0OM, S\u00f8reide\u00a0JA, Giljaca\u00a0V, Jureckova\u00a0A, Bulusu\u00a0VR. Global epidemiology of gastrointestinal stromal tumours (GIST): A systematic review of population-based cohort studies. Cancer Epidemiol. 2016;40:39\u201346.","journal-title":"Cancer Epidemiol"},{"issue":"Suppl 4","key":"965_CR5","doi-asserted-by":"publisher","first-page":"iv68","DOI":"10.1093\/annonc\/mdy095","volume":"29","author":"PG Casali","year":"2018","unstructured":"Casali\u00a0PG, Abecassis\u00a0N, Aro\u00a0HT, Bauer\u00a0S, Biagini\u00a0R, Bielack\u00a0S, et al. Gastrointestinal stromal tumours: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2018;29(Suppl 4):iv68\u201378.","journal-title":"Ann Oncol"},{"key":"965_CR6","unstructured":"Reichardt P, Bauer S, D\u00fcrr D, Hohenberger P, K\u00f6stler WJ, Pritzkuleit R, et\u00a0al. Gastrointestinale Stromatumoren (GIST). Onkopedia.. https:\/\/www.onkopedia.com\/de\/onkopedia\/guidelines\/gastrointestinale-stromatumoren-gist. Zugegriffen: 28. Aug. 2021."},{"key":"965_CR7","unstructured":"Bayerisches Krebsregister - Regionalzentrum M\u00fcnchen am Klinikum Gro\u00dfhadern\/IBE. Tumorregister M\u00fcnchen Survival GIST: Gastroint. Stromatumor. 2021. https:\/\/www.tumorregister-muenchen.de\/facts\/surv\/shGISTG-GIST-Gastroint.-Stromatumor-Survival.pdf. Zugegriffen: 28. Aug. 2021."},{"issue":"7","key":"965_CR8","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1038\/modpathol.2013.47","volume":"26","author":"S Huss","year":"2013","unstructured":"Huss\u00a0S, K\u00fcnstlinger\u00a0H, Wardelmann\u00a0E, Kleine\u00a0MA, Binot\u00a0E, Merkelbach-Bruse\u00a0S, et al. A subset of gastrointestinal stromal tumors previously regarded as wild-type tumors carries somatic activating mutations in KIT exon 8 (p.D419del). Mod Pathol. 2013;26(7):1004\u201312.","journal-title":"Mod Pathol"},{"issue":"11","key":"965_CR9","doi-asserted-by":"publisher","first-page":"4529","DOI":"10.1007\/s11695-020-04853-1","volume":"30","author":"JA Fern\u00e1ndez","year":"2020","unstructured":"Fern\u00e1ndez\u00a0JA, Frutos\u00a0MD, Ruiz-Manzanera\u00a0JJ. Incidental gastrointestinal Stromal tumors (GISTs) and Bariatric surgery: a review. Obes Surg. 2020;30(11):4529\u201341.","journal-title":"Obes Surg"},{"issue":"5","key":"965_CR10","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1159\/000494347","volume":"34","author":"L Tu","year":"2018","unstructured":"Tu\u00a0L, Hohenberger\u00a0P, Allgayer\u00a0H, Cao\u00a0H. Standard approach to gastrointestinal stromal tumors\u2014Differences between China and Europe. Visc Med. 2018;34(5):353\u20138.","journal-title":"Visc Med"},{"issue":"12","key":"965_CR11","doi-asserted-by":"publisher","first-page":"1854","DOI":"10.1002\/bjs.7222","volume":"97","author":"P Hohenberger","year":"2010","unstructured":"Hohenberger\u00a0P, Ronellenfitsch\u00a0U, Oladeji\u00a0O, Pink\u00a0D, Str\u00f6bel\u00a0P, Wardelmann\u00a0E, et\u00a0al. Pattern of recurrence in patients with ruptured primary gastrointestinal stromal tumour. Br J Surg. 2010;97(12):1854\u20139.","journal-title":"Br J Surg"},{"issue":"7","key":"965_CR12","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1007\/s00104-008-1528-4","volume":"79","author":"C Langer","year":"2008","unstructured":"Langer\u00a0C, Sch\u00fcler\u00a0P, Becker\u00a0H, Liersch\u00a0T. Gastrointestinale Stromatumoren aus chirurgischer Sicht. Chirurg. 2008;79(7):644.","journal-title":"Chirurg"},{"issue":"1","key":"965_CR13","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s13045-020-01026-6","volume":"14","author":"CM Kelly","year":"2021","unstructured":"Kelly\u00a0CM, Gutierrez Sainz\u00a0L, Chi\u00a0P. The management of metastatic GIST: current standard and investigational therapeutics. J\u00a0Hematol Oncol. 2021;14(1):2.","journal-title":"J Hematol Oncol"},{"key":"965_CR14","first-page":"1","volume":"22","author":"M Henriques-Abreu","year":"2021","unstructured":"Henriques-Abreu\u00a0M, Serrano\u00a0C. Avapritinib in unresectable or metastatic gastrointestinal stromal tumor with PDGFRA exon 18 mutation: safety and efficacy. Expert Rev Anticancer Ther. 2021;22:1\u20138.","journal-title":"Expert Rev Anticancer Ther"},{"issue":"3","key":"965_CR15","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1148\/radiol.2353040332","volume":"235","author":"S Shankar","year":"2005","unstructured":"Shankar\u00a0S, vanSonnenberg\u00a0E, Desai\u00a0J, Dipiro\u00a0PJ, Van Den Abbeele\u00a0A, Demetri\u00a0GD. Gastrointestinal stromal tumor: new nodule-within-a-mass pattern of recurrence after partial response to imatinib mesylate. Radiology. 2005;235(3):892\u20138.","journal-title":"Radiology"},{"key":"965_CR16","doi-asserted-by":"publisher","first-page":"672500","DOI":"10.3389\/fonc.2021.672500","volume":"11","author":"S Bauer","year":"2021","unstructured":"Bauer\u00a0S, George\u00a0S, von Mehren\u00a0M, Heinrich\u00a0MC. Early and next-generation KIT\/PDGFRA kinase inhibitors and the future of treatment for advanced gastrointestinal stromal tumor. Front Oncol. 2021;11:672500.","journal-title":"Front Oncol"},{"key":"965_CR17","doi-asserted-by":"publisher","first-page":"175883591879462","DOI":"10.1177\/1758835918794623","volume":"10","author":"B Vincenzi","year":"2018","unstructured":"Vincenzi\u00a0B, Nannini\u00a0M, Badalamenti\u00a0G, Grignani\u00a0G, Fumagalli\u00a0E, Gasperoni\u00a0S, et\u00a0al. Imatinib rechallenge in patients with advanced gastrointestinal stromal tumors following progression with imatinib, sunitinib and regorafenib. Ther Adv Med Oncol. 2018;10:1758835918794623.","journal-title":"Ther Adv Med Oncol"}],"container-title":["Wiener Medizinische Wochenschrift"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10354-022-00965-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10354-022-00965-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10354-022-00965-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,30]],"date-time":"2023-05-30T15:12:32Z","timestamp":1685459552000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10354-022-00965-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,26]]},"references-count":17,"journal-issue":{"issue":"9-10","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["965"],"URL":"https:\/\/doi.org\/10.1007\/s10354-022-00965-8","relation":{},"ISSN":["0043-5341","1563-258X"],"issn-type":[{"value":"0043-5341","type":"print"},{"value":"1563-258X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,26]]},"assertion":[{"value":"14 February 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 August 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"D.\u00a0Jaros, B.\u00a0Bozic und C.\u00a0Sebesta geben an, dass kein Interessenkonflikt besteht.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}